000908 logo

CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. Stock Price

SZSE:000908 Community·CN¥9.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

000908 Share Price Performance

CN¥6.05
0.26 (4.49%)
CN¥6.05
0.26 (4.49%)
Price CN¥6.05

000908 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with minimal risk.

1 Risk
0 Rewards

CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. Key Details

CN¥385.5m

Revenue

CN¥150.8m

Cost of Revenue

CN¥234.8m

Gross Profit

CN¥300.1m

Other Expenses

-CN¥65.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.037
60.89%
-16.94%
0.07%
View Full Analysis

About 000908

Founded
1998
Employees
463
CEO
Dong Yang
WebsiteView website
www.jfzhiyao.com

CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. manufactures and sells chemical drugs and biological agents in China. The company’s principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the fields of cardiovascular disease, orthopedic pain disease, tumor disease, women and children. The company was formerly known as Hunan Jingfeng Pharmaceutical Co.,Ltd. and changed its name to CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. in April 2026. The company was founded in 1998 and is headquartered in Changde, China.

Recent 000908 News & Updates

Recent updates

No updates